Article
Somatic alterations contributing to metastasis of a castration-resistant prostate cancer.
Human mutation - 1 Sept 2013
Nickerson Michael L, Im Kate M, Misner Kevin J, Tan Wei, Lou Hong, Gold Bert, Wells David W, Bravo Hector C, Fredrikson Karin M, Harkins Timothy T, Milos Patrice, Zbar Berton, Linehan W Marston, Yeager Meredith, Andresson Thorkell, Dean Michael, Bova G Steven
Abstract excerpt
Metastatic castration-resistant prostate cancer (mCRPC) is a lethal disease, and molecular markers that differentiate indolent from aggressive subtypes are needed. We sequenced the exomes of five metastatic tumors and healthy kidney tissue from an index case with mCRPC to identify lesions associa...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
